ResMed Announces Participation in the 23rd Annual Macquarie Australia Conference

Rhea-AI Summary

ResMed (NYSE: RMD) announced that CFO Brett Sandercock will present virtually at the Macquarie Australia Conference on May 5, 2021, at 8:45 a.m. AEST. This event will be accessible via video webcast, with a replay available for Macquarie clients 24 hours post-event until May 26, 2021. ResMed is known for its innovative digital health technologies and cloud-connected devices aimed at improving care for chronic diseases like sleep apnea and COPD, effectively transforming healthcare delivery worldwide.

Positive

• CFO will present at a major conference, potentially increasing investor interest.
• Company's commitment to innovative healthcare solutions may enhance long-term growth prospects.

Negative

• None.

SAN DIEGO, April 27, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Brett Sandercock, chief financial officer, will present virtually at the Macquarie Australia Conference on Wednesday, May 5, 2021, beginning at approximately 8:45 a.m. (Australian Eastern Standard Time) via video webcast.

More information about this event, including access to the live webcast, may be accessed by visiting http://investor.resmed.com. The webcast replay will be available to Macquarie clients approximately 24 hours after the live webcast ends and will be accessible through May 26, 2021.

About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.

For investors			For media
Amy Wakeham			Jayme Rubenstein
+1 858.836.5000			+1 858.836.6798
investorrelations@resmed.com			news@resmed.com

FAQ

When will ResMed's CFO present at the Macquarie Australia Conference?

Brett Sandercock, ResMed's CFO, will present on May 5, 2021, at approximately 8:45 a.m. AEST.

How can I access the webcast of ResMed's CFO presentation?

The webcast can be accessed through ResMed's investor relations website.

What is ResMed's stock symbol?

ResMed's stock symbol is RMD.

How does ResMed improve healthcare?

ResMed provides digital health technologies and cloud-connected devices that help manage chronic diseases, improving patient outcomes and reducing healthcare costs.